Part Details | FUROSEMIDE INJECTION
6505-01-157-5117
Alternate Parts: 28002, NDC63323028002, NDC63323-0280-02, NDC23155047341, NDC23155-0473-41, NDC00409610201, NDC00409-6102-01, NDC00517570225, NDC00517-5702-25, 6505-01-157-5117, 01-157-5117, 6505011575117, 011575117
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JUL 07, 1983 | 01-157-5117 | 30041 ( FUROSEMIDE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-157-5117
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 28002 | 57KZ6 | FRESENIUS KABI USA, LLC |
| NDC63323-0280-02 | 57KZ6 | FRESENIUS KABI USA, LLC |
| NDC23155-0473-41 | 5TB00 | HERITAGE PHARMACEUTICALS INCDBA HERITAGE PHARMAOEUTICALS AVE |
| NDC00409-6102-01 | 3VBU6 | HOSPIRA, INC. |
| NDC00517-5702-25 | 32288 | LUITPOLD PHARMACEUTICALS INCDBA OSTEOHEALTH COMPANY |
Technical Data | NSN 6505-01-157-5117
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY10.000 MILLIGRAMS FUROSEMIDE |
| PHARMACEUTICAL VEHICLE TYPE | B ANY ACCEPTABLE |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| SPECIAL FEATURES | AUTHORIZED SUB FOR NSN 6505-01-525-0326 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FUROSEMIDE INJECTION USP 10MG/ML 2ML VIAL 25S |